Momenta Pharmaceuticals
MNTA
#2673
Rank
ยฃ4.73 B
Marketcap
ยฃ39.78
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Revenue for Momenta Pharmaceuticals (MNTA)

Revenue in 2020 (TTM): ยฃ23.93 Million

According to Momenta Pharmaceuticals's latest financial reports the company's current revenue is ยฃ22.79 Million. In 2019 the company made a revenue of ยฃ18.09 Million a decrease over the revenue in the year 2018 that were of ยฃ57.29 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Momenta Pharmaceuticals from 2004 to 2020

Annual revenue

Year Revenue Change
2020 (TTM)ยฃ23.93 M32.33%
2019ยฃ18.09 M-68.42%
2018ยฃ57.29 M-45.57%
2017ยฃ0.10 B26.7%
2016ยฃ83.08 M22.28%
2015ยฃ67.94 M71.58%
2014ยฃ39.6 M47.33%
2013ยฃ26.87 M-44.52%
2012ยฃ48.44 M-77.42%
2011ยฃ0.21 B142.41%
2010ยฃ88.5 M476.68%
2009ยฃ15.34 M38.97%
2008ยฃ11.04 M-32.42%
2007ยฃ16.34 M31.7%
2006ยฃ12.4 M13.06%
2005ยฃ10.97 M84.86%
2004ยฃ5.93 M